206 related articles for article (PubMed ID: 33634228)
1. Fulminant eosinophilic myocarditis treated with steroids and mechanical unloading: a case report.
Balthazar T; Adriaenssens T; Droogne W; Vandenbriele C
Eur Heart J Case Rep; 2020 Dec; 4(6):1-5. PubMed ID: 33634228
[TBL] [Abstract][Full Text] [Related]
2. Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock.
Bohné M; Chung DU; Tigges E; van der Schalk H; Waddell D; Schenker N; Willems S; Klingel K; Kivelitz D; Bahlmann E
BMC Cardiovasc Disord; 2020 Dec; 20(1):519. PubMed ID: 33302874
[TBL] [Abstract][Full Text] [Related]
3. Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts.
Tschöpe C; Van Linthout S; Klein O; Mairinger T; Krackhardt F; Potapov EV; Schmidt G; Burkhoff D; Pieske B; Spillmann F
J Cardiovasc Transl Res; 2019 Apr; 12(2):116-123. PubMed ID: 30084076
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 fulminant myocarditis recovered with veno-arterial extracorporeal membrane oxygenation and Impella CP.
Matsushita S; Tada T; Sasaki W; Osakada K; Kawase Y; Kadota K
J Cardiol Cases; 2023 May; 28(3):116-9. PubMed ID: 37361643
[TBL] [Abstract][Full Text] [Related]
5. Significance of troponin I level as a marker of disease activity in the management of acute necrotizing eosinophilic myocarditis with normal peripheral eosinophil count: a case report.
Kakino T; Yokoyama H; Eshima K
Eur Heart J Case Rep; 2018 Dec; 2(4):yty139. PubMed ID: 31020215
[TBL] [Abstract][Full Text] [Related]
6. Fulminant lymphocytic myocarditis: Prediction of successful weaning from Impella support for cardiogenic shock.
Saegusa H; Komatsu J; Sugane H; Hosoda H; Imai RI; Nakaoka Y; Nishida K; Seki SI; Kubokawa SI; Kawai K; Hamashige N; Doi Y
J Cardiol Cases; 2022 Mar; 25(3):159-162. PubMed ID: 35261701
[TBL] [Abstract][Full Text] [Related]
7. Successful Bridge-to-Recovery Treatment in a Young Patient with Fulminant Eosinophilic Myocarditis: Roles of a Percutaneous Ventricular Assist Device and Endomyocardial Biopsy.
Hasegawa-Tamba S; Sugi K; Gatate Y; Sugiyama K; Muramatsu T; Nishimura S; Yasuda M; Fukushima K; Nakano S
Case Rep Emerg Med; 2019; 2019():8236735. PubMed ID: 31355017
[TBL] [Abstract][Full Text] [Related]
8. Fulminant myocarditis in a COVID-19 positive patient treated with mechanical circulatory support - a case report.
Papageorgiou JM; Almroth H; Törnudd M; van der Wal H; Varelogianni G; Lawesson SS
Eur Heart J Case Rep; 2021 Feb; 5(2):ytaa523. PubMed ID: 33594347
[TBL] [Abstract][Full Text] [Related]
9. Full myocardial recovery following COVID-19 fulminant myocarditis after biventricular mechanical support with BiPella: a case report.
Ajello S; Calvo F; Basso C; Nardelli P; Scandroglio AM
Eur Heart J Case Rep; 2022 Sep; 6(9):ytac373. PubMed ID: 36193160
[TBL] [Abstract][Full Text] [Related]
10. A case of a giant cell myocarditis that developed massive left ventricular thrombus during percutaneous cardiopulmonary support.
Takei Y; Ejima Y; Toyama H; Takei K; Ota T; Yamauchi M
JA Clin Rep; 2016; 2(1):41. PubMed ID: 29492436
[TBL] [Abstract][Full Text] [Related]
11. Fulminant Eosinophilic Myocarditis Without Peripheral Eosinophilia.
Lee JY; Lee SH; Kim WH
Tex Heart Inst J; 2023 Mar; 50(2):. PubMed ID: 37044058
[TBL] [Abstract][Full Text] [Related]
12. Rapid effect of benralizumab in fulminant eosinophilic myocarditis in the setting of uncontrolled eosinophilic asthma.
Goyack L; Garcha G; Shah R; Ortiz Gonzalez Y; Vollenweider M; Salimian M; Cheung W
J Cardiol Cases; 2023 Sep; 28(3):100-104. PubMed ID: 37671259
[TBL] [Abstract][Full Text] [Related]
13. A Survival Case of Fulminant Right-Side Dominant Eosinophilic Myocarditis.
Moriwaki K; Dohi K; Omori T; Tanimura M; Sugiura E; Nakamori S; Sawai T; Imanaka-Yoshida K; Yamada N; Ito M
Int Heart J; 2017 May; 58(3):459-462. PubMed ID: 28496024
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.
Ogawa S; Suzuki M; Ochi H; Saji M; Mahara K; Takamisawa I; Nishigawa K; Furuichi Y; Takanashi S; Isobe M
Intern Med; 2019 May; 58(10):1459-1462. PubMed ID: 30626823
[TBL] [Abstract][Full Text] [Related]
15. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry.
Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK
J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180
[TBL] [Abstract][Full Text] [Related]
16. Complete recovery of fulminant cytotoxic CD8 T-cell-mediated myocarditis after ECMELLA unloading and immunosuppression.
Jurcova I; Rocek J; Bracamonte-Baran W; Zelizko M; Netuka I; Maluskova J; Kautzner J; Cihakova D; Melenovsky V; Maly J
ESC Heart Fail; 2020 Aug; 7(4):1976-1981. PubMed ID: 32485066
[TBL] [Abstract][Full Text] [Related]
17. Fulminant necrotizing eosinophilic myocarditis after COVID-19 vaccination survived with mechanical circulatory support.
Kimura M; Hashimoto T; Noda E; Ishikawa Y; Ishikita A; Fujino T; Matsushima S; Ide T; Kinugawa S; Nagaoka K; Ushijima T; Shiose A; Tsutsui H
ESC Heart Fail; 2022 Aug; 9(4):2732-2737. PubMed ID: 35616026
[TBL] [Abstract][Full Text] [Related]
18. The "TIDE"-Algorithm for the Weaning of Patients With Cardiogenic Shock and Temporarily Mechanical Left Ventricular Support With Impella Devices. A Cardiovascular Physiology-Based Approach.
Tschöpe C; Spillmann F; Potapov E; Faragli A; Rapis K; Nelki V; Post H; Schmidt G; Alogna A
Front Cardiovasc Med; 2021; 8():563484. PubMed ID: 33681302
[No Abstract] [Full Text] [Related]
19. Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review.
Guglin ME; Etuk A; Shah C; Ilonze OJ
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902636
[TBL] [Abstract][Full Text] [Related]
20. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
